Renal safety of coformulated tenofovir/emtricitabine vs other nucleoside analogues in combination therapy in antiretroviral-naive patients aged 50 years or older in Spain: The TRIP study
暂无分享,去创建一个
J. Olalla | M. Riera | F. Pulido | P. Arazo | E. Pedrol | P. Domingo | F. Vera | A. M. Caro-Murillo | J. Gómez-Sirvent | J. R. Blanco Ramos | K. Aguirrebengoa | M. Castaño | A. Romero-Palacios | P. Ferrer